Stanford University
Showing 821-840 of 887 Results
-
Connie Juel
Professor of Education, Emerita
Current Research and Scholarly InterestsPoor Reading in Preterms: Neural Basis, Prediction, & Response to Intervention (with Heidi Feldman & Michal Ben Shachar). Five-year grant funded by NICHD, 2012-2017.
Effects of early elementary school instruction, and specific interventions, on literacy and language growth.
Longitudinal study of literacy development from preschool through first grade. Focus on classroom factors in 13 kindergarten and 13 first grade classrooms that affect growth across the years in children with different entering skill and language profiles. -
Riley Juenemann
Ph.D. Student in Computational and Mathematical Engineering, admitted Autumn 2021
BioThird-year Computational and Mathematical Engineering (ICME) PhD Candidate @ Stanford University passionate about research at the intersection of mathematics, computing, and biology.
-
Maximilian Julve
Clinical Assistant Professor, Medicine - Oncology
BioDr. Max Julve is a medical oncologist and Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine, with a clinical and research focus in solid tumor cellular therapy and melanoma.
Dr. Julve completed his medical training at Barts and The Royal London School of Medicine in the United Kingdom, followed by internal medicine training at teaching hospitals across North and Central London. He was subsequently awarded a National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship in Medical Oncology at Imperial College London. During this time, alongside his clinical training, he conducted translational research within the King’s College London Immunoengineering group, focusing on transcriptional optimization of CAR-T cell therapies.
Dr. Julve later completed advanced clinical fellowships in solid tumor cellular therapy and melanoma at The Royal Marsden Hospital, London, and earned an MD(Res) doctorate investigating the role of immunosuppressive granulocytes in patients receiving immunotherapy.
He is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor cellular therapy, with a particular emphasis on translating mechanistic insights from the laboratory into novel therapeutic strategies for patients.
